The field of central nervous system (CNS) drug development is awash with activit...
BMS' Breyanzi and Amgen’s Blincyto will now be available to patients in England ...
Incyte and Genesis have entered a strategic partnership for the research, discov...
Bluebird has faced financial pressures over the last few years, leading to sever...
Pfizer said resources will be directed to its other haemophilia gene therapy Hym...
UroGen Pharma has broadened its oncology pipeline by acquiring IconOVir Bio’s as...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for t...
AstraZeneca will gain full rights for roxadustat in China where it is approved t...
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants t...
X4 has entered an exclusive agreement with taiba rare for distributing and comme...
In this review, GlobalData considers the products both approved and priced in 20...
The World Health Organization (WHO) said it will conduct another mass vaccinatio...
ImmunityBio has gained the FDA authorisation for an EAP to supply an alternative...
The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the H...
FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for t...
